Press Release Summary:
- ISO 80369-7 compliant components are luer-activated
- Provide a safe and convenient method of delivering fluids
- Ideal for use in flushing, sampling and IV applications
Original Press Release:
Qosina Introduces New ISO 80369-7 Compliant Needleless Injection Sites
Ronkonkoma, NY, USA, February 4, 2019 - Qosina has introduced three new needleless, swabbable injection sites. These ISO 80369-7 compliant components are ideal for use in flushing, sampling and IV applications. They prevent dripping and leakage when disconnected, eliminating the need for clamps. And because they’re needleless, they provide a safer, more convenient method of delivering fluids.
These new injection sites are luer-activated, meaning when the male luer lock connects to the female luer lock, the stem opens the bidirectional valve, allowing for fluid transfer. The internal threads on the male luer match up with the external threads on the valve, creating a secure connection. Upon disconnection, the valve closes.
Qosina will be showcasing its new needleless injection sites, in addition to thousands of stock components, at Booth 2121 during MD&M West at the Anaheim Convention Center in Anaheim CA, February 5-7.
Founded in 1980, Qosina is a leading global supplier of OEM single-use components to the medical and pharmaceutical industries. Qosina’s philosophy is to address its customers’ need to reduce time to market by providing thousands of stock components. The company’s vast catalog features more than 5,000 products shown in full-scale illustrations on a one-centimeter grid. Qosina offers free samples of most items, low minimum order requirements, just-in-time delivery, modification of existing molds, and new product design and development. Qosina is ISO 9001, ISO 13485 and ISO 14001 certified, and operates in a 95,000 square-foot facility with an ISO Class 8 Clean Room. To learn about Qosina’s full component offering, which includes the newest products, visit www.qosina.com or call +1 (631) 242-3000.
+1 (631) 242-3000